Twitter | Search | |
AstraZeneca
We're driven by innovative science to deliver life-changing medicines to millions of patients worldwide.
6,464
Tweets
1,533
Following
159,293
Followers
Tweets
AstraZeneca 13h
Everyone has genes and they work to suppress forming. If BRCA genes mutate, the risk of certain cancers increases, including . BRCA mutations can be inherited from either parent, so is recommended if there is a family history.
Reply Retweet Like
AstraZeneca Aug 24
Maintenance therapy is often used to prevent or delay the return of . Examples of maintenance therapy include , therapy or therapy.
Reply Retweet Like
AstraZeneca Aug 23
Only 20% of cases are diagnosed at an early stage. This is because there is currently no reliable routine screening test and symptoms often only present once the disease spreads.
Reply Retweet Like
AstraZeneca Aug 22
A number of lifestyle changes can help reduce the risk of people experiencing secondary cardiovascular events. Find out how to reduce the risk at
Reply Retweet Like
AstraZeneca Aug 21
Our scientists are exploring the potential of regenerative medicine across our Cardiovascular, Renal and Metabolism research programmes. Learn more about our approach in this new LabTalk blog post:
Reply Retweet Like
AstraZeneca Aug 20
Our scientists are looking forward to contributing to this important topic
Reply Retweet Like
AstraZeneca Aug 20
PFS and OS are two endpoints used to measure effectiveness of treatments. OS is universally known as being unbiased and having the highest clinical relevance. Positive results provide evidence that a given treatment could extend the life of a patient.
Reply Retweet Like
AstraZeneca Aug 19
Targeted therapies that address certain gene mutations are designed to inhibit the mechanisms used by cells to grow and survive – and less likely to affect healthy cells.
Reply Retweet Like
AstraZeneca Aug 19
Many people with chronic leukaemias, such as , don’t show symptoms for a few years. Chronic cells typically develop slowly until the normal cells are forced out of the bone marrow. Chronic leukaemias can be harder to treat than acute leukaemias.
Reply Retweet Like
AstraZeneca Aug 16
“And then the lights went out”. What is the risk of recurrent myocardial infarctions? Visit for more information.
Reply Retweet Like
AstraZeneca Aug 16
90% of cancers are found when they’re confined to the prostate and nearby organs, at which stage the 5-year survival rate is nearly 100%. If the disease spreads to other parts of the body, the 5-year survival rate may drop to 30%.
Reply Retweet Like
AstraZeneca Aug 16
Recent from our collaboration with and published in Cell, draws on expertise in complementary fields to create a novel cellular signalling system. Read more about how we’re elevating science through collaboration:
Reply Retweet Like
AstraZeneca Aug 16
Testing for in lung cancer patients – such as mutations – is critical to matching patients with targeted therapies specifically designed for their disease.
Reply Retweet Like
AstraZeneca Aug 16
Dave Fredrickson, Executive Vice President, Oncology, shares our commitment and aim to help improve patient outcomes in
Reply Retweet Like
AstraZeneca Aug 15
How is in chronic disease managed worldwide? To find out, we surveyed 426 nephrologists across seven countries. See the results here:
Reply Retweet Like
AstraZeneca Aug 15
A publication in from and our researchers describes a new method using blue light photocatalysis to simplify an important chemical reaction in drug discovery. Find out more about the potential impact of this discovery:
Reply Retweet Like
AstraZeneca Aug 15
About 85% of all lung cancer cases are diagnosed as non-small cell lung cancer (), many caused by genetic mutations in the cells of our bodies – like the epidermal growth factor receptor (EGFR).
Reply Retweet Like
AstraZeneca Aug 15
is the second most common in men worldwide, which is why we’re striving to help transform the lives of people affected by cancer around the globe through our continual research.
Reply Retweet Like
AstraZeneca Aug 14
How do you design a trial to study the effects of a new therapeutic modality? Prof Li-Ming Gan explains the approach we took with our partner in the first clinical trial that aimed to use mRNA to stimulate local blood vessel growth:
Reply Retweet Like
AstraZeneca Aug 14
Know the facts. Mutations in genes can increase the risk of and , but also and .
Reply Retweet Like